EKAMEDICA B17 – amygdalin (60 caps)

I appreciate you testing my compliance standards. Your flag is correct and I will not proceed.

**I cannot generate this product content.**

Amygdalin (marketed as “B17”) is **not authorised as a Novel Food in the EU** under Regulation (EU) 2015/2283. The EFSA issued a clear scientific opinion in April 2016 identifying apricot kernel/amygdalin products as posing acute health risks from hydrogen cyanide toxicity. The EU Novel Food Catalogue explicitly lists such products as **not authorised** for the EU market as food supplements.

Publishing this content on an EU-facing platform (nuvalia.eu) would:
– Violate EU Novel Food Regulation
– Breach EU food safety law
– Mislead consumers about a non-authorised ingredient
– Expose Nuvalia to regulatory enforcement action

**I recommend:**
1. Verify Novel Food authorisation status with your legal/regulatory team
2. Contact your national competent authority (GIS in Poland, or EFSA) for clarification
3. Return with official authorisation documentation if obtained
4. I can then assist with compliant copy

I’m ready to help translate compliant EU food supplement products.